| Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants MT ul Qamar, SM Alqahtani, MA Alamri, LL Chen Journal of pharmaceutical analysis 10 (4), 313-319, 2020 | 896 | 2020 |
| Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study M Tahir ul Qamar, S Saleem, UA Ashfaq, A Bari, F Anwar, S Alqahtani Journal of translational medicine 17, 1-14, 2019 | 142 | 2019 |
| Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro MA Alamri, M Tahir Ul Qamar, MU Mirza, R Bhadane, SM Alqahtani, ... Journal of Biomolecular Structure and Dynamics 39 (13), 4936-4948, 2021 | 107 | 2021 |
| Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy R Chadar, O Afzal, SM Alqahtani, P Kesharwani Colloids and surfaces B: Biointerfaces 208, 112044, 2021 | 60 | 2021 |
| Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics MA Alamri, A Altharawi, AB Alabbas, MA Alossaimi, SM Alqahtani Arabian Journal of Chemistry 13 (9), 7224-7234, 2020 | 56 | 2020 |
| Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches MA Alamri, MT ul Qamar, MU Mirza, SM Alqahtani, M Froeyen, LL Chen Journal of pharmaceutical analysis 10 (6), 546-559, 2020 | 49 | 2020 |
| In vitro investigation on the impact of airway mucus on drug dissolution and absorption at the air-epithelium interface in the lungs E Cingolani, S Alqahtani, RC Sadler, D Prime, S Stolnik, C Bosquillon European Journal of Pharmaceutics and Biopharmaceutics 141, 210-220, 2019 | 41 | 2019 |
| Patent ductus arteriosus in premature infants: to treat or not to treat? MA Mohamed, M El-Dib, S Alqahtani, K Alyami, AN Ibrahim, H Aly Journal of Perinatology 37 (6), 652-657, 2017 | 41 | 2017 |
| Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation MA Alamri, MT ul Qamar, O Afzal, AB Alabbas, Y Riadi, SM Alqahtani Journal of molecular liquids 330, 115699, 2021 | 32 | 2021 |
| Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review MS Hussain, G Gupta, M Afzal, SM Alqahtani, VP Samuel, I Kazmi, ... Pathology-Research and Practice, 154908, 2023 | 23 | 2023 |
| Pharmacoinformatics and molecular dynamic simulation studies reveal potential inhibitors of SARS-CoV-2 main protease 3CLpro MA Alamri, MT ul Qamar, SM Alqahtani Preprints, 2020 | 18 | 2020 |
| Synthesis, characterization, biological evaluation and molecular docking of a new quinazolinone-based derivative as a potent dual inhibitor for VEGFR-2 and EGFR tyrosine kinases Y Riadi, MA Alamri, MH Geesi, EH Anouar, O Ouerghi, AB Alabbas, ... Journal of Biomolecular Structure and Dynamics 40 (15), 6810-6816, 2022 | 14 | 2022 |
| Novel and potential small molecule scaffolds as DYRK1A inhibitors by integrated molecular docking-based virtual screening and dynamics simulation study MM Shahroz, HK Sharma, ASA Altamimi, MA Alamri, A Ali, A Ali, ... Molecules 27 (4), 1159, 2022 | 12 | 2022 |
| Synthesis, anticancer screening of some novel trimethoxy quinazolines and VEGFR2, EGFR tyrosine kinase inhibitors assay; molecular docking studies AS Altamimi, AS El-Azab, SG Abdelhamid, MA Alamri, AH Bayoumi, ... Molecules 26 (10), 2992, 2021 | 10 | 2021 |
| Discovery of potential phytochemicals as inhibitors of TcdB, a major virulence factors of Clostridioides difficile MA Alamri, MH Tariq, M Tahir ul Qamar, AB Alabbas, SM Alqahtani, ... Journal of Biomolecular Structure and Dynamics 41 (22), 12768-12776, 2023 | 9 | 2023 |
| Hydro-Distilled and Supercritical Fluid Extraction of Eucalyptus camaldulensis Essential Oil: Characterization of Bioactives Along With Antioxidant, Antimicrobial … A Abbas, F Anwar, SM Alqahtani, N Ahmad, SH Al-Mijalli, M Shahid, ... Dose-Response 20 (3), 15593258221125477, 2022 | 9 | 2022 |
| Molecular and structural analysis of specific mutations from Saudi isolates of SARS-CoV-2 RNA-dependent RNA polymerase and their implications on protein structure and drug … MA Alamri, M Tahir ul Qamar, AB Alabbas, SM Alqahtani, MA Alossaimi, ... Molecules 27 (19), 6475, 2022 | 8 | 2022 |
| Development of an in vitro system to study the interactions of aerosolized drugs with pulmonary mucus S Alqahtani, CJ Roberts, S Stolnik, C Bosquillon Pharmaceutics 12 (2), 145, 2020 | 8 | 2020 |
| Method development, stability, and pharmacokinetic studies of acyclovir-loaded topical formulation in spiked rat plasma SM Alqahtani, A Altharawi, MA Altamimi, MA Alossaimi, WA Mahdi, ... Processes 10 (10), 2079, 2022 | 7 | 2022 |
| PP38. LIMITATION OF EXTERNAL LIPID SOURCES INDUCES DIFFERENTIAL PROLIFERATIVE AND MORPHOLOGICAL RESPONSES IN ADULT AND PAEDIATRIC GBM CELLS MJ Wood, DDH Kim, MS Alqahtani, DS Smith, PD Barrett, PR Grundy, ... Neuro-oncology 19 (suppl_1), i11-i11, 2017 | 7 | 2017 |
